Live Updates Live Coverage Updates appear automatically as they are published. Nasdaq up 300 at the Open 9:54 am Despite a poor outing on Friday, the Nasdaq just opened 300 points higher. All as inves
LLY eyes Q2 growth on Mounjaro and Zepbound momentum, but pricing pressure and rising competition test its edge.
While most investors pile into Eli Lilly (LLY 2.95%) or flee from struggling Novo Nordisk (NVO 2.48%), they're missing a compelling opportunity in the clinical-stage space. Novo recently lost nearly $

3 Unstoppable Stocks to Buy in August

06:45am, Saturday, 02'nd Aug 2025
The "it" factor. Some stocks have it.

Trim Your AI Stocks And Buy Eli Lilly

03:18pm, Friday, 01'st Aug 2025
AI and semiconductor stocks are too expensive right now. Don't buy them now, trim your high-tech positions, and buy healthcare stocks like Eli Lilly and Company. LLY is a hyper-growth-at-a-reasonable-
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
Eli Lilly (LLY) is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Analysts expect continued volume-driven revenue and margi
CNBC's Joe Kernen reports on the latest news.
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
CNBC's Angelica Peebles joins 'The Exchange' to discuss President Trump posting letters to 17 pharmaceutical companies about drug prices.
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Lilly (LLY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the older drug Trulicity.
CNBC's Angelica Peebles joins 'Squawk Box' with the latest news from Eli Lilly.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE